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As reimbursement policies and healthcare reform legislation add pressure onto the independent practice of car-
diology, many cardiology groups seek refuge in hospital employment. This has implications for healthcare costs
and the future of the practice of cardiology, especially in the age of accountable care organizations. (J Am Coll
Cardiol 2011;57:2139–40) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.12.031The private practice of cardiology has been under assault
since well before the Affordable Care Act (ACA) was signed
into law in March 2010 (1,2). White House healthcare
advisors recently described the administration’s vision of the
practice of medicine in the era of the ACA in the Annals of
Internal Medicine (3). While itemizing the desirable objec-
tives of the ACA, they drew a road map for physician
survival that excludes anything other than organization
into a large group or hospital employment. They called
this vertical organization.
Since 2007, the Centers for Medicare and Medicaid
ervices (CMS) has systematically reduced Medicare allow-
ble fees for outpatient cardiovascular imaging performed in
physician’s office. From 2007 to 2010 in Tennessee, CMS
as reduced office-based myocardial perfusion imaging fees
y 23% and echocardiographic fees by 31% (4). The
limination of Medicare’s reimbursement for consultation
odes in 2010 has inflicted further financial harm to
ardiology. Meanwhile, CMS has increased reimbursements
or hospital-based outpatient myocardial perfusion imaging
y 31% and echocardiographic imaging fees by 22% during
he same interval (4), and thus has created a large disparity
n payments for identical services performed in different
enues (Tennessee 2010 Medicare allowable fees for echo-
ardiography global [93306] in office $231.42, and in
ospital $495.29; myocardial perfusion imaging [78452] in
ffice $417.98, and in hospital $809.75 [4]). The resulting
conomic stress on private cardiology practices has caused
hem to run for the shelter of hospital employment in
roves. So, hospitals have not only been immune from these
ee reductions but see an opportunity for revenue increase by
he purchase of cardiology groups and redirection of previ-
usly lost imaging studies back to the hospital at increased
eimbursement levels.
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have been most sensitive to this economic stress while
smaller groups have continued to thrive, albeit by imple-
menting austere cost-containment strategies. This observa-
tion casts doubt upon the truth of “economy of scale,” but
also reveals a paradox about the economics of this move-
ment. When physician groups are purchased by hospitals,
the imaging studies ordered by the newly employed physi-
cians will be performed by the hospital and reimbursed at
higher fees than had been reimbursed previously. Unless
there is a large-scale reduction in the number of studies
performed (is there really that much savings to be had by
redefining the self-referral incentive from group employ-
ment to hospital employment?), the cost to the healthcare
system of these imaging studies will increase. Therefore, it
would seem that CMS’s reimbursement policies and the
incentives introduced by the ACA have the potential to
transform the practice of cardiology from a low-cost cottage
industry into a higher-cost, but vertically organized, big
business.
The push toward hospital employment raises an even
more important concern. Having practiced interventional
cardiology for two decades, I have been fortunate to partic-
ipate in the introduction of numerous new technologies that
represented proven advances in patient care, such as coro-
nary and peripheral vascular stenting, rotational ablation,
carotid stenting, abdominal aortic aneurysm stent grafting,
and drug-eluting stenting. Without exception, each of these
new technologies has resulted in increased costs to the
hospital, and without exception, each has been met with
resistance from hospital administrators. On one occasion, a
hospital administrator naively but honestly reported that the
administration opposed the adoption of rotational ablation
simply because it would “increase their costs.” On another,
the administration of a not-for-profit community hospital
decided it would save money in the late 1990s by forcing all
invasive cardiology procedures to use Renografin (Bracco
Diagnostics Inc., Princeton, New Jersey) rather than a more
expensive nonionic and lower osmolality contrast agent.
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Cardiology and Healthcare Reform May 24, 2011:2139–40Only after an epidemic of life-
threatening arrhythmias in the
catheterization laboratory did the
administration relent and allow
cardiologists to use their choice
of contrast agents. On yet an-
other occasion, and years before
the existence of any legitimate
controversy about the safety of drug-eluting stents, the chief
executive officer of a for-profit hospital distributed a corpo-
rate office–generated white paper to all cardiologists titled
“Drug Eluding [sic] Stents,” wherein grave concerns about
their efficacy were raised in stark financial terms.
Hospital administrators must be concerned with their
costs. That is their fiduciary duty. However, it is one thing
to be concerned about institutional costs and another to be
concerned about global healthcare costs. One determines
hospital profitability and the other healthcare system sus-
tainability. We should not confuse decreasing hospital costs
with savings to the healthcare system.
If hospital administrators appropriately protect the prof-
itability of the hospital, who will protect the medical interest
of the patient when the two are in conflict? That has been,
and must remain, the responsibility of the physician. That is
his or her fiduciary duty. When hospital and physician are
separate economic entities, there is some balance of author-
ity. When there is employment and consequent loss of
autonomy, will the physician be able to champion the
patient’s interest effectively?
I agree with the Obama administration’s view that reform
of the healthcare system is not optional—it is mandatory.
The United States cannot compete in a global economy
while it spends 16% of its gross domestic product on health
care with vast numbers of uninsured citizens, compared with
other industrialized countries that spend an average of 9% of
gross domestic product (5) with virtually no uninsured
citizens. Therefore, I have been a wary supporter of the
administration’s healthcare reform efforts, a lonely position
among physicians in the South. However, as CMS reim-
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Servicesbursement policies dictate, and as White House officialsarticulate the intent of the ACA, and thus the two give
shape to the practice of medicine for the future, I am left
wondering: Why should vertical organization be a synonym
for hospital employment? Does hospital employment really
translate into healthcare cost savings? Should small but
efficiently operated cardiology practices be discouraged from
forming ad hoc relationships with hospitals into accountable
care organizations? Or, would not independent provider
associations provide the same vehicle to accomplish the
laudable objectives of the ACA such as integration of care,
data sharing, and efficiency? Yet, to date, the Federal Trade
Commission has considered independent provider associa-
tions guilty of violating antitrust laws. Must our healthcare
system recognize only one model of delivery, that of hospital
employment? Without expanding the definition of vertical
organization, the days of the independent cardiologist are
limited. Thus, the voice advocating for the patient becomes
weaker, whereas cost savings are far from assured.
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